This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,540.12 firm fixed-price delivery order covers the supply of 4,566,628,304 units of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a part of that larger IDC. The contract award did not utilize any set-aside designation, indicating open competition.
Generated 3/6/25, 9:46 AM